<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33962805</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-5487</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Archives of medical research</Title><ISOAbbreviation>Arch Med Res</ISOAbbreviation></Journal><ArticleTitle>Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals.</ArticleTitle><Pagination><StartPage>575</StartPage><EndPage>581</EndPage><MedlinePgn>575-581</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.arcmed.2021.03.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0188-4409(21)00081-3</ELocationID><Abstract><AbstractText>Post-COVID syndrome also known as long COVID refers to symptoms persisting for more than three weeks after the diagnosis of COVID-19. We reviewed the current evidence on post-COVID syndrome, focusing on its clinical manifestations and addressing the challenges for its management in primary healthcare. The incidence of post-COVID syndrome is estimated at 10-35%, while for hospitalized patients it may reach 85%. Fatigue is the most common symptom reported in 17.5-72% of post-COVID cases, followed by residual dyspnea with an incidence ranging from 10-40%. Mental problems, chest pain, and olfactory and gustatory dysfunction may affect up to 26, 22 and 11% of patients, respectively. More than one third of patients with post-COVID syndrome have pre-existing comorbidities, hypertension and diabetes mellitus being the most common. Beyond the prolonged duration of symptoms, the scarce published data indicate that most patients with post-COVID syndrome have a good prognosis with no further complications or fatal outcomes reported. Given the clinical spectrum of patients with post-COVID syndrome, most of them will be managed by primary healthcare professionals, in conjunction with pre-existing or new co-morbidities, which, in turn, may increase the burden of COVID-19 on primary healthcare. In conclusion approximately 10% of patients with COVID-19 may have symptoms persisting beyond three weeks, fulfilling the criteria of post-COVID syndrome. Primary healthcare professionals have a key role in the management of patients with post-COVID syndrome. Research is needed to elucidate the pathogenesis, clinical spectrum, and prognosis of post-COVID syndrome.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pavli</LastName><ForeName>Androula</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Travel Medicine, National Public Health Organization, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theodoridou</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>First Department of Pediatrics, University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maltezou</LastName><ForeName>Helena C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Directorate of Research, Studies and Documentation, National Public Health Organization, Athens, Greece. Electronic address: helen-maltezou@ath.forthnet.gr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arch Med Res</MedlineTA><NlmUniqueID>9312706</NlmUniqueID><ISSNLinking>0188-4409</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Fatigue syndrome</Keyword><Keyword MajorTopicYN="N">Long term</Keyword><Keyword MajorTopicYN="N">Management</Keyword><Keyword MajorTopicYN="N">Post-infectious</Keyword><Keyword MajorTopicYN="N">Prevention</Keyword><Keyword MajorTopicYN="N">Primary healthcare</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33962805</ArticleId><ArticleId IdType="pmc">PMC8093949</ArticleId><ArticleId IdType="doi">10.1016/j.arcmed.2021.03.010</ArticleId><ArticleId IdType="pii">S0188-4409(21)00081-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kingstone T, Taylor AK, O'Donnell CA, et al. Finding the &#x201c;right&#x201d; GP: a qualitative study of the experiences of people with long-COVID. BJGP Open. 2020;4 bjgpopen20X101143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7880173</ArticleId><ArticleId IdType="pubmed">33051223</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute of Health Director's blog. Post-covid syndrome. Available at https://directorsblog.nih.gov/tag/post-covid-syndrome/(Accessed March 15, 2021).</Citation></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court M, et al. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhavana V, Thakor P, Singh SB, et al. COVID-19: pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV-2 pandemic. Life Sci. 2020;2020(261)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7443335</ArticleId><ArticleId IdType="pubmed">32846164</ArticleId></ArticleIdList></Reference><Reference><Citation>Alpert O, Begun L, Gerren P, et al. Cytokine storm induced new onset depression in patients with COVID-19. A new look into the association between depression and cytokines &#x2013; two case reports. Brain Behav Immun Health. 2020;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7606074</ArticleId><ArticleId IdType="pubmed">33163979</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M, Kim S, Lindsell C, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network &#x2013; United States, March&#x2013;June 2020. MMWR Morb Mortal Wkly Rep. 2020;69:993&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Covid-19-long-term-health-effects. Available at https://www.gov.uk/government/publications/covid-19-long-term-health-effects/covid-19-long-term-health-effects (Accessed March 15, 2021).</Citation></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Simani L, Ramezani M, Darazam IA, et al. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. J Neurovirol. 2021;27:154&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852482</ArticleId><ArticleId IdType="pubmed">33528827</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi R, et al. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Addison AB, Wong B, Ahmed T, et al. Clinical Olfactory Working Group Consensus Statement on the Treatment of Post Infectious Olfactory Dysfunction. J Allergy Clin Immunol. 2021 doi: 10.1016/j.jaci.2020.12.641. S0091-6749(21)00004-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.12.641</ArticleId><ArticleId IdType="pubmed">33453291</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bon SD, Pisarski N, Verbeke J, et al. Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients. Eur Arch Otorhinolaryngol. 2020;278:101&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402072</ArticleId><ArticleId IdType="pubmed">32754871</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez JM, et al. COVID19-ALC research Post-acute COVID-19 Syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021 doi: 10.1016/j.jinf.2021.01.004. S0163-4453(21)00009-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg P, Arora U, Kumar A, et al. The &#x201c;post-COVID&#x201d; syndrome: How deep is the damage? J Med Virol. 2021;93:673&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461449</ArticleId><ArticleId IdType="pubmed">32852801</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang L, Yang B, Jiang N, et al. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge. J Korean Med. Sci. 2020;35:e418. doi: 10.3346/jkms.2020.35.e418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e418</ArticleId><ArticleId IdType="pmc">PMC7721559</ArticleId><ArticleId IdType="pubmed">33289374</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt EG, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021;93:1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27:258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81:e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et&#xa0;al. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. Available at https://www.medrxiv.org/content/10.1101/2020.12.24.20248802v2 (Accessed March 15, 2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.24.20248802v2</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo PE, et al. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge. JAMA Netw Open. 2021;4 doi: 10.1001/jamanetworkopen.2020.36142. PMID: 33502487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.36142</ArticleId><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Soloveva NV, Makarova EV, Kichuk IV. Coronavirus syndrome: COVID-19 psychotrauma. Eur J Transl Myol. 2021;30:9302. doi: 10.4081/ejtm.2020.9302. eCollection 2020 Dec 31.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/ejtm.2020.9302</ArticleId><ArticleId IdType="pmc">PMC7844407</ArticleId><ArticleId IdType="pubmed">33520144</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang MC, Park D. Incidence of Post-Traumatic Stress Disorder After Coronavirus Disease. Health care (Basel) 2020;8:373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7712968</ArticleId><ArticleId IdType="pubmed">33008081</ArticleId></ArticleIdList></Reference><Reference><Citation>Sher L. Post-COVID syndrome and suicide risk. QJM. 2021:hcab007. doi: 10.1093/qjmed/hcab007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab007</ArticleId><ArticleId IdType="pmc">PMC7928695</ArticleId><ArticleId IdType="pubmed">33486531</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie K, Chan D, Watermeyer T. The cognitive consequences of the COVID-19 epidemic: collateral damage? Brain Commun. 2020;2:fcaa069. doi: 10.1093/braincomms/fcaa069. eCollection 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa069</ArticleId><ArticleId IdType="pmc">PMC7314157</ArticleId><ArticleId IdType="pubmed">33074266</ArticleId></ArticleIdList></Reference><Reference><Citation>Raahimi MM, Kane A, Moore CE, et al. Late onset of Guillain-Barre syndrome following SARS-CoV-2 infection: part of 'long COVID-19 syndrome'? BMJ Case Rep. 2021;14 doi: 10.1136/bcr-2020-240178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-240178</ArticleId><ArticleId IdType="pmc">PMC7813388</ArticleId><ArticleId IdType="pubmed">33462068</ArticleId></ArticleIdList></Reference><Reference><Citation>Camdessanche JP, Morel J, Pozzetto B, et al. COVID-19 may induce Guillain-Barr&#xe9; syndrome. Rev Neurol (Paris) 2020;176:516&#x2013;518. doi: 10.1016/j.neurol.2020.04.003. Epub 2020.PMID: 32334841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2020.04.003</ArticleId><ArticleId IdType="pmc">PMC7158797</ArticleId><ArticleId IdType="pubmed">32334841</ArticleId></ArticleIdList></Reference><Reference><Citation>Emamikhah M, Babadi M, Mehrabani M, et al. Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature. J Neurovirol. 2021:1&#x2013;9. doi: 10.1007/s13365-020-00941-1. Online ahead of print. PMID: 33492608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-020-00941-1</ArticleId><ArticleId IdType="pmc">PMC7831695</ArticleId><ArticleId IdType="pubmed">33492608</ArticleId></ArticleIdList></Reference><Reference><Citation>Scoppettuolo P, Borrelli S, Naeije G. Neurological involvement in SARS-CoV-2 infection: A clinical systematic review. Brain Behav Immun Health. 2020;5 doi: 10.1016/j.bbih.2020.100094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100094</ArticleId><ArticleId IdType="pmc">PMC7832728</ArticleId><ArticleId IdType="pubmed">33521692</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahali H, Ghasemi A, Farahani RH, et al. Acute transverse myelitis after SARS-CoV-2 infection: a rare complicated case of rapid onset paraplegia. J Neurovirol. 2021:1&#x2013;5. doi: 10.1007/s13365-021-00957-1. Online ahead of print. (Accessed March 15, 2021)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-00957-1</ArticleId><ArticleId IdType="pmc">PMC7920546</ArticleId><ArticleId IdType="pubmed">33650074</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilbertus S. Acute transverse myelitis attributed to SARS-CoV-2 infection presenting as impaired mobility: a case report. CJEM. 2021 doi: 10.1007/s43678-021-00104-z. 1&#x2013;2Online ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43678-021-00104-z</ArticleId><ArticleId IdType="pmc">PMC7917167</ArticleId><ArticleId IdType="pubmed">33646523</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O'Malley M, et al. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Ann Intern Med. 2020:M20&#x2013;5661. doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker RC. COVID-19 and its sequelae: a platform for optimal patient care, discovery and training. J Thromb Thrombolysis. 2021:1&#x2013;8. doi: 10.1007/s11239-021-02375-w. Online ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-021-02375-w</ArticleId><ArticleId IdType="pmc">PMC7838017</ArticleId><ArticleId IdType="pubmed">33501596</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, et al. Persistent symptoms after Covid-19: qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Serv Res. 2020;20:1144. doi: 10.1186/s12913-020-06001-y. PMID: 33342437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA, Attree E, Blair JM, et al. From doctors as patients: a manifesto for tackling persisting symptoms of COVID-19. BMJ. 2020;370:m3565.</Citation><ArticleIdList><ArticleId IdType="pubmed">32933949</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettigrew LM, Kumpunen S, Mays N. Primary care networks: the impact of covid-19 and the challenges ahead. BMJ. 2020;370:m3353. doi: 10.1136/bmj.m3353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3353</ArticleId><ArticleId IdType="pubmed">32883685</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza CD, Gois-Santos VT, Correia DS, et al. The need to strengthen Primary Health Care in Brazil in the context of the COVID-19 pandemic. Braz Oral Res. 2020;34:e047. doi: 10.1590/1807-3107bor-2020.vol34.0047. Epub 2020 May 11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1807-3107bor-2020.vol34.0047</ArticleId><ArticleId IdType="pubmed">32401828</ArticleId></ArticleIdList></Reference><Reference><Citation>Swankoski KE, Peikes DN, Palakal M, et al. Primary care practice transformation introduces different staff roles. Ann Fam Med. 2020;18:227&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7213997</ArticleId><ArticleId IdType="pubmed">32393558</ArticleId></ArticleIdList></Reference><Reference><Citation>Royal Australian College of General Practitioners. Caring for adult patients with post-COVID-19 conditions. Available at https://www.racgp.org.au/FSDEDEV/media/documents/RACGP/Coronavirus/Post-COVID-19-conditions.pdf (Accessed March 15, 2021).</Citation></Reference><Reference><Citation>Holmes EA, O'Connor RC, Perry VH, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7:547&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159850</ArticleId><ArticleId IdType="pubmed">32304649</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly C, Ashcroft R, Bobbette N, et al. Interprofessional primary care during COVID-19: a survey of the provider perspective. BMC Fam Pract. 2021;22:31. doi: 10.1186/s12875-020-01366-9. PMID: 33535973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12875-020-01366-9</ArticleId><ArticleId IdType="pmc">PMC7857097</ArticleId><ArticleId IdType="pubmed">33535973</ArticleId></ArticleIdList></Reference><Reference><Citation>Assaf G, Davis H, McCorkell L, et al.  An analysis of the prolonged COVID-19 symptoms survey by Patient-Led Research Team. Patient Led Research. 2020 https://patientresearchcovid19.com/ Available at. (Accessed March 15, 2021)</Citation></Reference><Reference><Citation>Office for National Statistics  Analysis of death registrations not involving coronavirus (covid-19-19) England and Wales. June 2020 https://www.ons.gov.uk/releases/analysisofdeathregistrationsnotassociatedwithcoronaviruscovid19englandandwalesjanuary2020tomay2020 28 December 2019 to 1 May 2020 Available at. Accessed March 15, 2021.</Citation></Reference><Reference><Citation>Use of primary care during the COVID-19 pandemic. Patient-level data analysis of the impact of COVID-19 on primary care activity in England. Available at https://www.health.org.uk/news-and-comment/charts-and-infographics/use-of-primary-care-during-the-covid-19-pandemic (Accessed March 15, 2021).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>